Introduction Antimicrobial resistance (AMR) is a major global health threat. According to the CDC (2019), over 2.8 million antibiotic-resistant infections
INCACARE
FOCUS ON INTENSIVE CARE.
Welcome To
Incacare Live
Incacare Live is an initiative by Concord Biotech to keep you updated with recent advances in critical care. The website shares information regarding incidences of opportunistic fungal infections in patients.
Concord Biotech is a vertically integrated, R&D driven biotechnological powerhouse manufacturing API’s and Finished formulations, offers products across diversified therapeutic segments.
Blog
INTENSIVE CARE UPDATES
Introduction Antibiotic-resistant bacteria are a growing global threat, causing longer hospital stays, higher costs, and increased mortality. The rise of
Introduction Invasive fungal infections (IFI) are life-threatening in ICU patients, with rising incidence and persistently high mortality. The increase is
Introduction (Article introduction authored by INCA Editorial Team) Bacterial pneumonia remains a global health challenge with high morbidity and mortality,
Introduction Ventilator-associated pneumonia (VAP) is a common and serious infection in ICU patients who undergo invasive mechanical ventilation for more
Introduction Respiratory distress is the leading cause of NICU admissions. Rapid diagnosis and appropriate treatment are vital for improving outcomes.
